Repeated exposure to methamphetamine causes long-lasting presynaptic corticostriatal depression that is renormalized with drug readministration.

Neuron
Nigel S BamfordDavid Sulzer

Abstract

Addiction-associated behaviors such as drug craving and relapse are hypothesized to result from synaptic changes that persist long after withdrawal and are renormalized by drug reinstatement, although such chronic synaptic effects have not been identified. We report that exposure to the dopamine releaser methamphetamine for 10 days elicits a long-lasting (>4 month) depression at corticostriatal terminals that is reversed by methamphetamine readministration. Both methamphetamine-induced chronic presynaptic depression and the drug's selective renormalization in drug-experienced animals are independent of corresponding long-term changes in synaptic dopamine release but are due to alterations in D1 dopamine and cholinergic receptor systems. These mechanisms might provide a synaptic basis that underlies addiction and habit learning and their long-term maintenance.

References

May 1, 1992·Trends in Pharmacological Sciences·G F Koob
May 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·C Le MoineB Bloch
Jul 1, 1994·Journal of Neuroscience Methods·N BertrandA Beley
Aug 1, 1997·The Journal of Pharmacology and Experimental Therapeutics·M J Bickerdike, E D Abercrombie
Nov 27, 1999·Science·M S JogA M Graybiel
Feb 17, 2000·Trends in Neurosciences·P CalabresiG Bernardi
Nov 19, 2002·Journal of Neurobiology·Michael W Quick, Robin A J Lester
Apr 12, 2003·Trends in Neurosciences·Gregory L GerdemanDavid M Lovinger
Dec 4, 2003·Molecular Pharmacology·Laura A Volpicelli-DaleyAllan I Levey
Apr 23, 2004·Synapse·Deborah SiegalStephen J Kish
May 18, 2004·Nature Neuroscience·Hui Zhang, David Sulzer
Oct 29, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nigel S BamfordCharles K Meshul
Dec 14, 2004·Science·A David Redish
Dec 17, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Timothy J Turner
Jan 27, 2005·Neurochemistry International·Colin DavidsonEverett H Ellinwood
May 26, 2005·Brain Research. Brain Research Reviews·Hai Wang, Xiulan Sun
Jun 2, 2005·The European Journal of Neuroscience·Jukka S PakkanenRaimo K Tuominen
Jun 16, 2005·Progress in Neurobiology·David SulzerAurelio Galli
Jul 15, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Anne Marie BradyPatricio O'Donnell

❮ Previous
Next ❯

Citations

Mar 25, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Beau M AncesUNKNOWN HIV Neurobehavioral Research Center (HNRC) Group
Jan 13, 2009·Nature Neuroscience·Khaled MoussawiPeter W Kalivas
Dec 27, 2013·Nature Neuroscience·Ege T Kavalali, Erik M Jorgensen
Dec 29, 2010·Proceedings of the National Academy of Sciences of the United States of America·Yunmin DingUn Jung Kang
Jun 16, 2009·Schizophrenia Bulletin·Gholson J LyonDavid Sulzer
Jun 21, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Wengang WangNigel S Bamford
Feb 27, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Prasad R JoshiNigel S Bamford
Jul 10, 2010·Expert Opinion on Drug Safety·Richard Lawrence Merkel
May 16, 2012·The Journal of Physiology·Wengang WangNigel S Bamford
Jun 28, 2011·Progress in Neurobiology·Michael W Shiflett, Bernard W Balleine
Oct 25, 2008·Behavioural Brain Research·Massimiliano Di FilippoPaolo Calabresi
Dec 24, 2010·Bipolar Disorders·William R Marchand, Deborah Yurgelun-Todd
Dec 12, 2012·Annals of Neurology·Wengang WangNigel S Bamford
Feb 15, 2012·Journal of Neuroendocrinology·E Trudel, C W Bourque
Jul 20, 2010·Drug and Alcohol Review·Rebecca McKetinKerri Lawrence
Apr 17, 2015·Annals of the New York Academy of Sciences·Kalynda K Gonzales, Yoland Smith
Jun 23, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Marc Deffains, Hagai Bergman
Jun 13, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jakub JedynakMark J Thomas
Nov 29, 2008·Neuron·Anatol C Kreitzer, Robert C Malenka
Oct 9, 2014·Postgraduate Medicine·David B Clemow, Daniel J Walker
Mar 2, 2010·Nature Neuroscience·Eric Trudel, Charles W Bourque
Jul 13, 2019·Journal of Neuroscience Research·Nigel S Bamford, Wengang Wang
Aug 2, 2017·International Journal of Mental Health and Addiction·Chunqing LinLi Li
Jan 27, 2019·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Ian J Bamford, Nigel S Bamford
Dec 2, 2020·Brain Sciences·Ziqing ShiNigel S Bamford
Jan 11, 2021·Pharmacology, Biochemistry, and Behavior·Steven T PittengerRick A Bevins
Oct 28, 2019·The Lancet Child & Adolescent Health·Nigel S Bamford, Kathryn McVicar
Aug 3, 2011·The Medical Journal of Australia·Rebecca McKetinTim N Slade

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain developing: Influences & Outcomes

This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Related Papers

British Journal of Pharmacology
M W Feltenstein, R E See
Nature Reviews. Neuroscience
Julie A Kauer, Robert C Malenka
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Nigel S BamfordCharles K Meshul
© 2022 Meta ULC. All rights reserved